40 studies found for:    prostate cancer screening | Open Studies
Show Display Options
Rank Status Study
21 Recruiting A Phase 2 Open-Label Study to Evaluate the Efficacy and Safety of VT-464 in Patients With Metastatic Castration Resistant Prostate Cancer Who Have Previously Been Treated With Enzalutamide
Conditions: Prostate Cancer;   Prostatic Neoplasms;   Neoplasms, Prostate
Intervention: Drug: VT-464
22 Recruiting Free Fatty Acid Metabolite Biomarkers for Cancer
Conditions: Prostate Cancer;   Breast Cancer;   Colon Cancer;   Lung Cancer
Intervention: Other: blood sample
23 Not yet recruiting Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate
Condition: Prostate Cancer
Interventions: Radiation: hypofractionation;   Radiation: conventional
24 Recruiting Prevention of Lymphoceles After Robotic PLND
Conditions: Lymphoceles;   Prostate Cancer
Intervention: Device: Intuitive Vessel Sealer
25 Not yet recruiting Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer
Condition: Prostate Cancer
Intervention: Other: 18F-FCH PET/MRI imaging
26 Recruiting Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR
Conditions: Prostatic Neoplasms;   Breast Neoplasms;   Colorectal Neoplasms;   Melanoma;   Leukemia
Intervention: Behavioral: Interactive Voice Response (IVR) Reminders
27 Recruiting Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.
Conditions: Metastatic Castrate-Resistant Prostate Cancer (mCRPC),;   Efficacy,;   Safety and Tolerability,;   Pharmacokinetics,;   Pharmacodynamics,;   Tumour Response.
Intervention: Drug: Intermittent dosing of AZD5363
28 Unknown  The Effect of Radiation on Semen Quality and Fertility in Men With Prostate Cancer
Condition: Prostate Cancer
Intervention:
29 Recruiting A Randomized Phase IIa Efficacy and Safety Study of
Condition: Prostatic Neoplasms
Interventions: Drug: Radium-223 dichloride (Xofigo,BAY88-8223);   Drug: Abiraterone acetate;   Drug: Prednisone;   Drug: Enzalutamide
30 Unknown  PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition
Condition: Prostate Cancer
Intervention:
31 Recruiting Promotora-based Latino Family CVD Risk Reduction
Conditions: Heart Disease;   Cancer
Interventions: Behavioral: Home environs-based lifestyle counseling;   Behavioral: Cancer early detection
32 Recruiting Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
Interventions: Device: Comprehensive computed tomography of the abdomen/pelvis;   Other: Limited Malignancy Screening
33 Recruiting A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors
Condition: Solid Tumors
Intervention: Biological: OMP-54F28
34 Recruiting Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
Conditions: Breast Cancer;   Bladder Cancer;   Kidney Cancer;   Colon Cancer;   Prostate Cancer;   Lung Cancer
Intervention: Genetic: PCR/PCR/LDR Strategy
35 Unknown  A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
Condition: Prostatic Hyperplasia
Intervention: Drug: ML-04A
36 Recruiting Urine Proteome of Surgical Patients and Healthy Volunteers
Condition: Renal Cell Cancer
Intervention:
37 Unknown  Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI
Conditions: Hepatocellular Carcinoma;   Hepatitis B;   Hepatitis C
Intervention:
38 Unknown  Association of Colorectal Cancer With Nutrition, Diet, Obesity, Diabetes Mellitus, and Genetic Alterations in Taiwan
Condition: Colorectal Cancer
Intervention:
39 Recruiting Feasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells Bronchial Carcinomas
Condition: Non-small Cell Lung Cancer Metastatic
Intervention: Biological: CTC
40 Recruiting Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells
Condition: Melanoma
Interventions: Drug: Poly ICLC;   Procedure: leukapheresis

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page
Indicates status has not been verified in more than two years